Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK
Crossref DOI link: https://doi.org/10.1007/s13300-017-0250-y
Published Online: 2017-03-27
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vega-Hernandez, Gabriela
Wojcik, Radek
Schlueter, Max
Text and Data Mining valid from 2017-03-27
Article History
Received: 6 December 2016
First Online: 27 March 2017